Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs
- PMID: 15754040
Evaluation of proteasome-inhibitory and apoptosis-inducing potencies of novel (-)-EGCG analogs and their prodrugs
Abstract
The anti-cancer and cancer-preventive effects of green tea and its main constituent (-)-epigallocatechin gallate [(-)-EGCG] are well documented by a variety of studies, including epidemiological, cell culture, animal, and clinical studies. While (-)-EGCG remains the most potent polyphenol in green tea, it is very unstable in neutral or alkaline conditions (i.e. physiologic pH). In an effort to discover more stable polyphenol proteasome inhibitors, we synthesized several novel (-)-EGCG analogs with -OH groups eliminated from the B- and/or D-rings. In addition, we also synthesized their putative prodrugs with -OH groups protected by peracetate that can be removed by cellular cytosolic esterases. We first examined the structure-activity relationship of these unprotected and protected compounds to their proteasome-inhibitory potentials. We found that decreasing -OH groups from either the B- or D-ring leads to diminished proteasome-inhibitory activity in vitro. However, in cultured tumor cells only the protected analogs were capable of potently inhibiting the proteasome activity. Furthermore, these protected analogs induced apoptotic cell death in a tumor cell-specific manner. The superior efficacy of the protected (-)-EGCG analogs indicates the formation of an entirely new compound(s) in intact tumor cells. These data suggest that the B-ring/D-ring peracetate-protected EGCG analogs have great potential to be developed into novel anti-cancer and cancer-preventive agents.
Similar articles
-
Green tea polyphenols as a natural tumour cell proteasome inhibitor.Inflammopharmacology. 2008 Oct;16(5):208-12. doi: 10.1007/s10787-008-8017-8. Inflammopharmacology. 2008. PMID: 18815743 Free PMC article. Review.
-
A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.Cancer Res. 2007 May 1;67(9):4303-10. doi: 10.1158/0008-5472.CAN-06-4699. Cancer Res. 2007. PMID: 17483343
-
Methylation suppresses the proteasome-inhibitory function of green tea polyphenols.J Cell Physiol. 2007 Oct;213(1):252-60. doi: 10.1002/jcp.21124. J Cell Physiol. 2007. PMID: 17477351
-
Molecular targets for the cancer preventive activity of tea polyphenols.Mol Carcinog. 2006 Jun;45(6):431-5. doi: 10.1002/mc.20228. Mol Carcinog. 2006. PMID: 16652355 Review.
-
A potential prodrug for a green tea polyphenol proteasome inhibitor: evaluation of the peracetate ester of (-)-epigallocatechin gallate [(-)-EGCG].Bioorg Med Chem. 2004 Nov 1;12(21):5587-93. doi: 10.1016/j.bmc.2004.08.002. Bioorg Med Chem. 2004. PMID: 15465336
Cited by
-
Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets.Molecules. 2024 Mar 20;29(6):1373. doi: 10.3390/molecules29061373. Molecules. 2024. PMID: 38543009 Free PMC article. Review.
-
Unlocking the power of nanomedicine: the future of nutraceuticals in oncology treatment.Front Nutr. 2023 Nov 17;10:1258516. doi: 10.3389/fnut.2023.1258516. eCollection 2023. Front Nutr. 2023. PMID: 38045808 Free PMC article. Review.
-
Epigallocatechin-3-gallate and cancer: focus on the role of microRNAs.Cancer Cell Int. 2023 Oct 14;23(1):241. doi: 10.1186/s12935-023-03081-8. Cancer Cell Int. 2023. PMID: 37838685 Free PMC article. Review.
-
Green Tea Polyphenol (-)-Epigallocatechin-3-Gallate (EGCG): A Time for a New Player in the Treatment of Respiratory Diseases?Antioxidants (Basel). 2022 Aug 13;11(8):1566. doi: 10.3390/antiox11081566. Antioxidants (Basel). 2022. PMID: 36009285 Free PMC article. Review.
-
Green Tea Epigallocatechin-3-Gallate Regulates Autophagy in Male and Female Reproductive Cancer.Front Pharmacol. 2022 Jul 4;13:906746. doi: 10.3389/fphar.2022.906746. eCollection 2022. Front Pharmacol. 2022. PMID: 35860020 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources